Emostasi e Trombosi, Società Italiana di. 2026. “PO49 | PROPHYLACTIC ANTICOAGULATION DECISIONS IN HIGH-RISK PATIENTS RECEIVING CANCER-DIRECTED THERAPY: ANALYSIS OF THE VERMONT METHOD: J. Barker1, K. Libby1, C. Holmes2, K. Martin2 | 1University of Vermont Health System; 2Department of Medicine, University of Vermont, Burlington, VT, USA”. Bleeding, Thrombosis and Vascular Biology 5 (s1). https://doi.org/10.4081/btvb.2026.541.